Richard C. Woodman
Directeur/Membre du Conseil chez H3 Biomedicine, Inc.
Postes actifs de Richard C. Woodman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Directeur/Membre du Conseil | 11/01/2022 | - |
Historique de carrière de Richard C. Woodman
Anciens postes connus de Richard C. Woodman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TRAWS PHARMA, INC. | Directeur Technique/Scientifique/R&D | 07/11/2018 | 15/01/2021 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Directeur Technique/Scientifique/R&D | 01/01/2006 | 01/03/2018 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2002 | 01/01/2006 |
| EISAI CO., LTD. | Corporate Officer/Principal | - | - |
| University of Calgary | Corporate Officer/Principal | 01/01/1990 | - |
Formation de Richard C. Woodman
| University of Calgary | Doctorate Degree |
| University of British Columbia | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 3 |
| Japon | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| EISAI CO., LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Bourse
- Insiders
- Richard C. Woodman
- Expérience
